Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Epivax
AddedFeb 15, 2024
UpdatedJun 18, 2026
Epivax

Epivax

Seed

EpiVax, a US-based immunology company, excels in computational immunology analysis.

HQ
Providence, RI, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

EpiVax, founded in Providence, United States, is an immunology company specializing in computational immunology analysis. The company's core mission is to lead advancements in immunogenicity risk assessment, immune modulation, and rapid vaccine design. EpiVax offers comprehensive analytical capabilities that support the development of safer and more effective therapeutics and vaccines. Their market focus includes biopharmaceutical companies and research institutions seeking to enhance the safety and efficacy of their immunological products.

Notable affiliated individuals include the President of AmbioPharm, Inc., who has praised EpiVax for their detailed scientific reports and transparency. EpiVax has achieved significant milestones in the field of computational immunology, contributing to the development of critical vaccines and therapeutics. Their impact is evident in their ability to provide timely and reliable scientific support, fostering a culture of innovation and collaboration within the immunology community.

Epivax - Similar Companies

EpiVax Oncology logo

EpiVax Oncology

epivaxtx.com

Agilvax logo

Agilvax

Vaccinex logo

Vaccinex

vaccinex.com

Pathovax logo

Pathovax

pathovax.com

Alphavax logo

Alphavax

alphavax.com

InvVax logo

InvVax

inv-vax.com

X-Vax Technology logo

X-Vax Technology

Vaxform logo

Vaxform

vaxform.com

Altravax logo

Altravax

altravax.com

GeoVax Labs logo

GeoVax Labs

geovax.com

NeuImmune logo

NeuImmune

neuimmune.com

Centivax logo

Centivax

centivax.com

Uvax Bio logo

Uvax Bio

uvaxbio.com

PaxVax logo

PaxVax

Imvax logo

Imvax

imvax.com

Epivax - Quick Facts

Who are Epivax's competitors?

Companies similar to Epivax include EpiVax Oncology, Agilvax, Vaccinex and Pathovax.

When was Epivax founded?

Epivax was founded in 1998.

Where is Epivax's headquarters located?

Epivax's headquarters is located in Providence, RI, US.

When was Epivax's last funding round?

Epivax's most recent funding round was for $2M (USD) in September 2022.

How much has Epivax raised to-date?

As of Sep 12, 2022, Epivax has raised a total of $6.6M (USD).

How many employees does Epivax have?

Epivax has 15 employees as of Feb 4, 2024.

Epivax - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • United States
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Vaccine Design
Tags
  • Biotech
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
  • 5610Restaurants and mobile food service activities
Show 23 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 720000Accommodation and Food Services
  • 722000Food Services and Drinking Places
  • 722500Restaurants and Other Eating Places
  • 722510Restaurants and Other Eating Places
  • 722511Full-Service Restaurants
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 5800Eating and drinking places
  • 5810Eating And Drinking Places
  • 5812Eating Places
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified